All In Biotech

Drug Trial Radar · NCT06881784

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

RASolve 301: Phase 3 Multicenter, Open Label, Randomized Study of RMC-6236 Versus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic RAS[MUT] NSCLC

Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 590 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

590

Planned (sponsor's estimate)

Start

May 6, 2025

Primary completion

Dec 1, 2027

Study completion Dec 1, 2030

Sponsor

Lead sponsor
Revolution Medicines, Inc.Industry
Sponsor type
Industry
First posted
Mar 18, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to docetaxel.

Conditions

  • NSCLC (Non-small Cell Lung Cancer)
  • Non-Small Cell Lung Cancer
  • NSCLC
  • NSCLC (Non-small Cell Lung Carcinoma)
  • NSCLC (Advanced Non-small Cell Lung Cancer)

Interventions

  • daraxonrasibDrug

    oral tablets

  • docetaxelDrug

    intravenous (IV) infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression free survival (PFS) per Blinded Independent Central Review (BICR) in the RAS G12X-C population (i.e RAS G12X excluding G12C)Time frame: Up to approximately 4 years
  2. Overall survival (OS) in the RAS G12X-C populationTime frame: Up to approximately 4 years

Locations

199 sites in 19 countries. Site status is shown where the registry gives one.

  • Alabama Oncology

    Birmingham, Alabama · Active not recruiting

  • Loma Linda University

    Loma Linda, California · Active not recruiting

  • MemorialCare Long Beach Medical Center

    Long Beach, California · Active not recruiting

  • UC Irvine Health

    Orange, California · Recruiting

  • UCHealth Memorial Hospital Central

    Colorado Springs, Colorado · Active not recruiting

  • Yale University, Smillow Cancer Center

    New Haven, Connecticut · Active not recruiting

  • Florida Cancer Specialists & Research Institute - South

    Fort Myers, Florida · Active not recruiting

  • BRCR Global

    Plantation, Florida · Active not recruiting

  • Florida Cancer Specialists & Research Institute - North

    St. Petersburg, Florida · Active not recruiting

  • Cleveland Clinic Martin North

    Stuart, Florida · Active not recruiting

  • Florida Cancer Specialists & Research Institute - East

    West Palm Beach, Florida · Active not recruiting

  • University Cancer and Blood Center

    Athens, Georgia · Active not recruiting

  • Piedmont Healthcare, Inc

    Atlanta, Georgia · Active not recruiting

  • Winship Cancer Institute

    Atlanta, Georgia · Active not recruiting

  • Rush University Medical Center

    Chicago, Illinois · Active not recruiting

  • University of Illinois Cancer Center

    Chicago, Illinois · Active not recruiting

  • University of Chicago Medical Center

    Chicago, Illinois · Active not recruiting

  • Community Health Network

    Indianapolis, Indiana · Active not recruiting

  • University of Iowa Health Care Cancer Services Quad Cities

    Bettendorf, Iowa · Active not recruiting

  • University of Iowa Hospitals & Clinics

    Iowa City, Iowa · Active not recruiting

  • University of Iowa Health Care, Mission Cancer + Blood

    Waukee, Iowa · Active not recruiting

  • The University of Kansas Cancer Center

    Westwood, Kansas · Active not recruiting

  • University of Maryland Greenebaum Comprehensive Cancer Center.

    Baltimore, Maryland · Active not recruiting

  • Johns Hopkins University of Medicine

    Baltimore, Maryland · Active not recruiting

  • Trinity Health Ann Arbor Hospital

    Ann Arbor, Michigan · Active not recruiting

  • Karmanos Cancer Institute

    Detroit, Michigan · Active not recruiting

  • Brigitte Harris Cancer Pavilion BHCP

    Detroit, Michigan · Active not recruiting

  • Washington University School of Medicine - Siteman Cancer Center

    St Louis, Missouri · Active not recruiting

  • St. Vincent Frontier Cancer Center

    Billings, Montana · Active not recruiting

  • Comprehensive Cancer Centers of Nevada

    Henderson, Nevada · Active not recruiting

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire · Active not recruiting

  • John Theurer Cancer Center at Hackensack UMC

    Hackensack, New Jersey · Active not recruiting

  • Morristown Medical Center (MMCORC)

    Morristown, New Jersey · Active not recruiting

  • Roswell Park Cancer Institute

    Buffalo, New York · Active not recruiting

  • Memorial Sloan Kettering Cancer Center

    New York, New York · Active not recruiting

  • Montefiore Medical Center

    The Bronx, New York · Active not recruiting

  • UNC Lineberger Comprehensive Cancer Center at University of North Carolina

    Chapel Hill, North Carolina · Active not recruiting

  • TriHealth Cancer & Blood Institute Research

    Cincinnati, Ohio · Active not recruiting

  • Taylor Cancer Research Center

    Maumee, Ohio · Active not recruiting

  • Oncology Associates of Oregon PC

    Eugene, Oregon · Active not recruiting

Showing 40 of 199 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.